4//SEC Filing
Hill, Mitch C. 4
Accession 0001127602-24-023899
CIK 0001531048other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:35 PM ET
Size
13.4 KB
Accession
0001127602-24-023899
Insider Transaction Report
Form 4
Hill, Mitch C.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-12$0.46/sh+3,000$1,371→ 182,600 total - Sale
Common Stock
2024-09-12$45.80/sh−891$40,808→ 180,100 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-09-12−3,000→ 58,477 totalExercise: $0.46Exp: 2029-04-23→ Common Stock (3,000 underlying) - Sale
Common Stock
2024-09-12$44.38/sh−1,609$71,407→ 180,991 total - Sale
Common Stock
2024-09-12$46.34/sh−500$23,170→ 179,600 total
Holdings
- 1,600(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $44.13 to $44.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $45.24 to $46.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $46.24 to $46.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter.
Documents
Issuer
Inari Medical, Inc.
CIK 0001531048
Entity typeother
Related Parties
1- filerCIK 0001644989
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:35 PM ET
- Size
- 13.4 KB